|
Platelet function inhibitors
Citations 1-10 of 218 total displayed.
|
Most recent content
(31 Aug 2008):
|
- Articles
Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38
- Stephen D. Wiviott, Eugene Braunwald, Dominick J. Angiolillo, Simha Meisel, Anthony J. Dalby, Freek W.A. Verheugt, Shaun G. Goodman, Ramon Corbalan, Drew A. Purdy, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman for the TRITON-TIMI 38 Investigators
Circulation published August 31, 2008, doi:10.1161/CIRCULATIONAHA.108.791061
[Abstract]
|
Past content
(since Oct 2000):
|
- Editorials
Intracoronary Administration of Abciximab in ST-Elevation Myocardial Infarction
- C. Michael Gibson, Cafer Zorkun, and Vijayalakshmi Kunadian
Circulation 2008; 118: 6-8, doi:10.1161/CIRCULATIONAHA.108.780718
[Full text]
- Interventional Cardiology
Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial
- Holger Thiele, Kathrin Schindler, Josef Friedenberger, Ingo Eitel, Georg Fürnau, Eigk Grebe, Sandra Erbs, Axel Linke, Sven Möbius-Winkler, Dietmar Kivelitz, and Gerhard Schuler
Circulation 118: 49 -57; published online before print as doi:10.1161/CIRCULATIONAHA.107.747642
[Abstract]
[Full text]
- Articles
Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial
- Holger Thiele, Kathrin Schindler, Josef Friedenberger, Ingo Eitel, Georg Fürnau, Eigk Grebe, Sandra Erbs, Axel Linke, Sven Möbius-Winkler, Dietmar Kivelitz, and Gerhard Schuler
Circulation published June 16, 2008, doi:10.1161/CIRCULATIONAHA.107.747642
[Abstract]
- Coronary Heart Disease
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation 117: 2865 -2874; published online before print as doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
[Full text]
- Articles
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleiman, David A. Vorchheimer, Nicholas Chronos, Chiara Melloni, John H. Alexander, Robert A. Harrington, Ross M. Tonkens, Richard C. Becker, and Christopher P. Rusconi
Circulation published May 27, 2008, doi:10.1161/CIRCULATIONAHA.107.745687
[Abstract]
- Editorials
Damage Control for Renal Artery Stenting
- John A. Bittl
Circulation 2008; 117: 2724-2726, doi:10.1161/CIRCULATIONAHA.108.776732
[Full text]
- Pediatric Cardiology
Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children: Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial
- Jennifer S. Li, Eric Yow, Katherine Y. Berezny, Paula M. Bokesch, Matsato Takahashi, Thomas P. Graham, Jr, Stephen P. Sanders, Daniel Sidi, Damien Bonnet, Peter Ewert, Lisa K. Jennings, Alan D. Michelson for the PICOLO Investigators
Circulation 117: 553 -559; published online before print as doi:10.1161/CIRCULATIONAHA.107.715821
[Abstract]
[Full text]
- Articles
Dosing of Clopidogrel for Platelet Inhibition in Infants and Young Children. Primary Results of the Platelet Inhibition in Children On cLOpidogrel (PICOLO) Trial
- Jennifer S. Li, Eric Yow, Katherine Y. Berezny, Paula M. Bokesch, Matsato Takahashi, Thomas P. Graham, Jr, Stephen P. Sanders, Daniel Sidi, Damien Bonnet, Peter Ewert, Lisa K. Jennings, Alan D. Michelson for the PICOLO Investigators
Circulation published January 14, 2008, doi:10.1161/CIRCULATIONAHA.107.715821
[Abstract]
- Coronary Heart Disease
Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial
- Stephen D. Wiviott, Dietmar Trenk, Andrew L. Frelinger, Michelle O’Donoghue, Franz-Josef Neumann, Alan D. Michelson, Dominick J. Angiolillo, Hanoch Hod, Gilles Montalescot, Debra L. Miller, Joseph A. Jakubowski, Richard Cairns, Sabina A. Murphy, Carolyn H. McCabe, Elliott M. Antman, Eugene Braunwald for the PRINCIPLE-TIMI 44 Investigators
Circulation 116: 2923 -2932; published online before print as doi:10.1161/CIRCULATIONAHA.107.740324
[Abstract]
[Full text]
|
|
